Literature DB >> 6833336

Estimation of liver tumor volume using different formulas - an experimental study in rats.

G Carlsson, B Gullberg, L Hafström.   

Abstract

Experimental solitary ellipsoid liver tumors in the rat can be induced by inoculation of a tumor-cell suspension of known potency into the liver parenchyma. During laparotomy, the largest (a) and the smallest (b) superficial diameters of the tumor were measured on the surface of the liver with vernier calipers. Four different formulas have been tested and compared with the actual volume from the extirpated tumor and tumor weight. Within the size range of 15-700 mm3, based on the calculation of the difference between logarithmic tumor volume from the different formulas versus logarithmic volume of extirpated and dissected tumors and regression analyses, volume of the unremoved liver tumor can be best calculated according to the formula V = a x b2/2.

Entities:  

Mesh:

Year:  1983        PMID: 6833336     DOI: 10.1007/bf00391826

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  19 in total

1.  Experimental factors influencing hepatic metastases. XII. Effect of increased arterial blood flow.

Authors:  S H LEE; B FISHER; E R FISHER
Journal:  Proc Soc Exp Biol Med       Date:  1963-01

2.  A report on some observations with a simplified cytotoxic test.

Authors:  E A BOYSE; L J OLD; G THOMAS
Journal:  Plast Reconstr Surg       Date:  1962-04       Impact factor: 4.730

3.  The effect of alteration of liver blood flow upon experimental hepatic metastases.

Authors:  B FISHER; E R FISHER; S H LEE
Journal:  Surg Gynecol Obstet       Date:  1961-01

4.  Experimental studies of factors influencing hepatic metastases. III. Effect of surgical trauma with special reference to liver injury.

Authors:  B FISHER; E R FISHER
Journal:  Ann Surg       Date:  1959-10       Impact factor: 12.969

5.  Experimental studies of factors influencing hepatic metastases. I. The effect of number of tumor cells injected and time of growth.

Authors:  E R FISHER; B FISHER
Journal:  Cancer       Date:  1959 Sep-Oct       Impact factor: 6.860

6.  Experimental evidence in support of the dormant tumor cell.

Authors:  B FISHER; E R FISHER
Journal:  Science       Date:  1959-10-09       Impact factor: 47.728

7.  Cross-reacting tumor-associated antigen (s) among chemically induced rat colon carcinomas.

Authors:  G Steele; H O Sjögren
Journal:  Cancer Res       Date:  1974-08       Impact factor: 12.701

8.  Analysis of tumor growth curves.

Authors:  L A Dethlefsen; J M Prewitt; M L Mendelsohn
Journal:  J Natl Cancer Inst       Date:  1968-02       Impact factor: 13.506

9.  Kinetic parameters and growth curves for experimental tumor systems.

Authors:  L Simpson-Herren; H H Lloyd
Journal:  Cancer Chemother Rep       Date:  1970-06

10.  Cellular proliferation patterns in an experimental rhabdomyosarcoma in the rat.

Authors:  A F Hermens; G W Barendsen
Journal:  Eur J Cancer       Date:  1967-11       Impact factor: 9.162

View more
  85 in total

1.  [Experimental research about effectiveness of transarterial chemoembolization (TACE) in an animal model of hepatocellular carcinoma].

Authors:  J Qian; G Feng; L Trübenbach; P L Pereira; P E Huppert; C D Claussen
Journal:  J Tongji Med Univ       Date:  2001

2.  [Experimental study on the effectiveness of transarterial chemoembolization with poly-lactide-Co-glycoside microspheres].

Authors:  Jun Qian; J Trübenbach; F Gräpler; P L Pereira; G Wiemann; E Thomas; P E Huppert; C D Claussen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

3.  Combined transarterial chemoembolization and arterial administration of Bletilla striata in treatment of liver tumor in rats.

Authors:  Jun Qian; Daryusch Vossoughi; Dirk Woitaschek; Elsie Oppermann; Wolf O Bechstein; Wei-Yong Li; Gan-Sheng Feng; Thomas Vogl
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

4.  [Establishment of hepatocellular carcinoma model by allogenic transplantation ].

Authors:  J Qian; G Feng; J Trübenbach; P E Huppert; P L Pereira; C D Claussen
Journal:  J Tongji Med Univ       Date:  2001

5.  Intraarterial hepatic chemotherapy with fluorouracil, fluorodeoxyuridine, mitomycin C, cisplatin or methotrexate as single-agent anticancer drugs for a transplanted experimental liver tumor in rats.

Authors:  S Kurth; D Bulian; B Kreft; T Riemenschneider
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

6.  A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.

Authors:  Uwe Reusch; Johannes Duell; Kristina Ellwanger; Carmen Herbrecht; Stefan Hj Knackmuss; Ivica Fucek; Markus Eser; Fionnuala McAleese; Vera Molkenthin; Fabrice Le Gall; Max Topp; Melvyn Little; Eugene A Zhukovsky
Journal:  MAbs       Date:  2015       Impact factor: 5.857

7.  Incorporation of pyrimidines and 5-fluoropyrimidines into normal tissues and an adenocarcinoma transplanted into the liver in rat.

Authors:  P I Christensson; C Erichsen; P E Jönsson; U Stenram
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

8.  Influence of zymosan (a non-specific macrophage stimulator) and of indomethacin on liver tumours--an experimental study in rats.

Authors:  S B Holmberg; P L Naredi; G O Lindnér; I H Karlberg; P L Daneryd; L M Karlsson; A Pettersson; U Stenram; L R Hafström
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

9.  Therapeutic efficacy of 188Re-liposome in a C26 murine colon carcinoma solid tumor model.

Authors:  Ya-Jen Chang; Chin-Wei Hsu; Chih-Hsien Chang; Keng-Li Lan; Gann Ting; Te-Wei Lee
Journal:  Invest New Drugs       Date:  2012-12-09       Impact factor: 3.850

10.  Characterization of Lewis lung clonal variants in a model of syngeneic pulmonary murine metastases.

Authors:  Bill T Storey; H Keith Pittman; Joseph F Christian; Carl E Haisch; Kathryn M Verbanac
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.